NO20005813D0 - Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater - Google Patents

Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater

Info

Publication number
NO20005813D0
NO20005813D0 NO20005813A NO20005813A NO20005813D0 NO 20005813 D0 NO20005813 D0 NO 20005813D0 NO 20005813 A NO20005813 A NO 20005813A NO 20005813 A NO20005813 A NO 20005813A NO 20005813 D0 NO20005813 D0 NO 20005813D0
Authority
NO
Norway
Prior art keywords
amplification
agents
activity
arginine derivatives
antibacterial oxazolidinone
Prior art date
Application number
NO20005813A
Other languages
English (en)
Other versions
NO20005813L (no
Inventor
Michael John Bohanon
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20005813L publication Critical patent/NO20005813L/no
Publication of NO20005813D0 publication Critical patent/NO20005813D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005813A 1998-05-18 2000-11-17 Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater NO20005813D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8116498A 1998-05-18 1998-05-18
PCT/US1999/007038 WO1999059616A1 (en) 1998-05-18 1999-05-13 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives

Publications (2)

Publication Number Publication Date
NO20005813L NO20005813L (no) 2000-11-17
NO20005813D0 true NO20005813D0 (no) 2000-11-17

Family

ID=22162494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005813A NO20005813D0 (no) 1998-05-18 2000-11-17 Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater

Country Status (24)

Country Link
US (1) US6251869B1 (no)
EP (1) EP1077718B1 (no)
JP (1) JP2002515450A (no)
KR (1) KR20010043695A (no)
CN (1) CN1170584C (no)
AT (1) ATE222115T1 (no)
AU (1) AU746606B2 (no)
BR (1) BR9910443A (no)
CA (1) CA2327100A1 (no)
CZ (1) CZ291945B6 (no)
DE (1) DE69902526T2 (no)
DK (1) DK1077718T3 (no)
EA (1) EA003458B1 (no)
ES (1) ES2182521T3 (no)
HU (1) HUP0101958A3 (no)
IL (1) IL139437A0 (no)
NO (1) NO20005813D0 (no)
NZ (1) NZ508256A (no)
PL (1) PL344049A1 (no)
PT (1) PT1077718E (no)
SK (1) SK283038B6 (no)
TR (1) TR200003384T2 (no)
WO (1) WO1999059616A1 (no)
ZA (1) ZA200005923B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US20050255538A1 (en) * 2002-03-15 2005-11-17 Buxser Stephen E Methods for screening for AcrAB efflux pump inhibitors
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CN1976703A (zh) * 2004-06-30 2007-06-06 诺瓦提斯公司 通过使用外排泵抑制剂增加肽脱甲酰基酶抑制剂敏感性的方法
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US8188270B2 (en) 2005-10-04 2012-05-29 Bayer Schering Pharma Aktiengesellschaft Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
EP3967312A1 (en) 2014-09-12 2022-03-16 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
CN1211384C (zh) * 1997-07-11 2005-07-20 法玛西雅厄普约翰美国公司 噻二唑基和噁二唑基苯基噁唑烷酮抗菌剂
US6068972A (en) * 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

Also Published As

Publication number Publication date
SK16252000A3 (sk) 2001-06-11
SK283038B6 (sk) 2003-02-04
BR9910443A (pt) 2001-01-02
HUP0101958A3 (en) 2003-07-28
NO20005813L (no) 2000-11-17
AU746606B2 (en) 2002-05-02
CZ20004259A3 (en) 2001-05-16
PT1077718E (pt) 2002-12-31
CA2327100A1 (en) 1999-11-25
TR200003384T2 (tr) 2001-03-21
ATE222115T1 (de) 2002-08-15
NZ508256A (en) 2003-08-29
HK1036222A1 (en) 2001-12-28
DE69902526T2 (de) 2003-04-03
EA003458B1 (ru) 2003-06-26
PL344049A1 (en) 2001-09-24
CN1170584C (zh) 2004-10-13
CN1297355A (zh) 2001-05-30
EP1077718B1 (en) 2002-08-14
IL139437A0 (en) 2001-11-25
ZA200005923B (en) 2001-10-23
AU3860199A (en) 1999-12-06
DE69902526D1 (de) 2002-09-19
EP1077718A1 (en) 2001-02-28
CZ291945B6 (cs) 2003-06-18
KR20010043695A (ko) 2001-05-25
EA200001197A1 (ru) 2001-04-23
WO1999059616A1 (en) 1999-11-25
JP2002515450A (ja) 2002-05-28
HUP0101958A2 (hu) 2001-10-28
US6251869B1 (en) 2001-06-26
DK1077718T3 (da) 2002-11-11
ES2182521T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
NO20005813D0 (no) Forsterking av aktiviteten til antibakterielle oksazolidinonmidler ved anvendelse av argininderivater
AP2003002824A0 (en) Gyrase inhibitors and uses thereof
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
ES2182234T3 (es) Inhibidores de metaloproteasa.
UY26380A1 (es) Inhibidores de fab i
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
DK1273299T3 (da) Minoxidilinindeholdende praparater
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
EP1171428A4 (en) FAB-I INHIBITORS
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ATE242630T1 (de) Beladene bakterienghosts als träger- und targetingvehikel
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
NO970340D0 (no) Organiske forbindelser
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
LV12375A (lv) 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana
TR199902097A2 (xx) Mikrobial transformasyon.
AU6908801A (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application